- Home
- THFF vs CRMD Comparison
THFF vs CRMD Comparison
Compare THFF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- CRMD
- Stock Information
- Founded
- THFF 1984
- CRMD 2006
- Country
- THFF United States
- CRMD United States
- Employees
- THFF N/A
- CRMD N/A
- Industry
- THFF Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- CRMD Health Care
- Exchange
- THFF Nasdaq
- CRMD Nasdaq
- Market Cap
- THFF 686.6M
- CRMD 865.2M
- IPO Year
- THFF N/A
- CRMD 2010
- Fundamental
- Price
- THFF $51.56
- CRMD $10.18
- Analyst Decision
- THFF Buy
- CRMD Strong Buy
- Analyst Count
- THFF 3
- CRMD 8
- Target Price
- THFF $59.50
- CRMD $17.57
- AVG Volume (30 Days)
- THFF 63.4K
- CRMD 2.2M
- Earning Date
- THFF 10-24-2025
- CRMD 11-10-2025
- Dividend Yield
- THFF 3.96%
- CRMD N/A
- EPS Growth
- THFF 21.43
- CRMD N/A
- EPS
- THFF 5.24
- CRMD 0.79
- Revenue
- THFF $230,446,000.00
- CRMD $121,484,498.00
- Revenue This Year
- THFF $30.73
- CRMD $480.51
- Revenue Next Year
- THFF $2.82
- CRMD $59.81
- P/E Ratio
- THFF $9.84
- CRMD $12.86
- Revenue Growth
- THFF 19.59
- CRMD 14970.29
- 52 Week Low
- THFF $41.91
- CRMD $5.60
- 52 Week High
- THFF $63.04
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- THFF 31.54
- CRMD 33.70
- Support Level
- THFF $52.15
- CRMD $10.39
- Resistance Level
- THFF $55.01
- CRMD $10.94
- Average True Range (ATR)
- THFF 1.36
- CRMD 0.45
- MACD
- THFF -0.34
- CRMD -0.07
- Stochastic Oscillator
- THFF 3.89
- CRMD 9.71
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.